Drug Trial Radar · NCT06996951
Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
64
Planned (sponsor's estimate)
Start
Jul 2, 2025
Primary completion
Jul 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- Indiana UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- American Rhinologic Society
- First posted
- May 30, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The investigators are doing this study to discover if it is appropriate for people with Cystic Fibrosis (CF) on highly effective modulator therapy (HEMT) to stop using certain standard Sino nasal therapies such as high-volume nasal saline irrigations, topical nasal steroids, and topical nasal antibiotics. They are also going to study the fluid inside the nose to see if there are changes when stopping these therapies. Right now, they are not sure if it is suggested to stop these treatments when patients begin highly effective modulator therapy (HEMT)
Conditions
- Cystic Fibrosis (CF)
- Chronic Rhinosinusitis (CRS)
Interventions
STOP NASAL SALINE IRRIGATION WITH OR WITHOUT STEROIDOther
PATIENT WILL STOP USING NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID
CONTINUE NASAL SALINE IRRIGATION WITH OR WITHOUT STEROIDDrug
PATIENT WILL CONTINUE USING NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Lund Kennedy ScoreTime frame: Baseline, 12 weeks
- Change in Pulmonary Function TestingTime frame: Baseline, 12 weeks
- Change in Body Mass Index (BMI)Time frame: Baseline, 12 weeks
- Change in Health Care UtilizationTime frame: Baseline, 12 weeks
- Change in Sinonasal Outcome Test 22 Questionnaire (SNOT-22) ScoreTime frame: Baseline, 12 weeks
- Change in Cystic Fibrosis Questionnaire-Revised (CFQ-R) ScoreTime frame: Baseline, 12 weeks
- Change in Patient Health Questionnaire-9 (PHQ-9) ScoreTime frame: Baseline, 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Indiana University Health
Indianapolis, Indiana · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.